解读抗原处理机器 (APM) 作为受影响患者对抗癌免疫治疗反应的决定因素之一
1Research Center for Vaccine and Drugs, The National Research and Innovation Agency (BRIN), South Tangerang 15310, Republic of Indonesia.
Asian Pacific journal of cancer prevention : APJCP
|December 29, 2024
概括
免疫检查点抑制剂 (ICI) 通过增强免疫反应,在癌症治疗中表现有前途. 然而,它们的有效性取决于抗原处理机制 (APM) 和人类白细胞抗原 (HLA) 呈现,这些在瘤中经常受到损害.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 免疫疗法,特别是免疫检查点抑制剂 (ICI),是癌症治疗的重大进展.
- 瘤细胞经常通过降低抗原处理机械 (APM) 组件和人类白细胞抗原 (HLA) 分子来逃避免疫检测.
- 有效的T细胞介导抗癌免疫需要通过HLA分子对瘤抗原进行适当的呈现.
研究的目的:
- 审查抗原处理机器 (APM) 和人类白细胞抗原 (HLA) 呈现在抗癌免疫治疗中的关键作用.
- 要强调瘤中APM和HLA呈现的损伤如何限制像ICI这样的免疫疗法的疗效.
- 强调HLA受限抗原呈现对于成功的T细胞原始化和瘤根除的重要性.
主要方法:
- 关于免疫疗法,免疫检查点抑制剂 (ICI),抗原处理机器 (APM) 和人类白细胞抗原 (HLA) 呈现的研究文献综述.
- 分析瘤通过APM和HLA的变化来逃避免疫监测的机制.
- 综合当前关于瘤抗原,HLA和T细胞反应之间的相互作用的理解.
主要成果:
- 损坏的APM成分和减少的HLA表达在瘤中很常见,阻碍了免疫识别.
- 在APM中发生的变化会影响T淋巴细胞呈现的抗原的谱.
- 成功的T细胞激活和细胞毒性作用因子的功能取决于-HLA复合物的精确相互作用.
结论:
- 恢复HLA受限制的瘤特异抗原呈现对于提高免疫疗法的疗效至关重要.
- 忽视APM和HLA在抗原呈现中的作用,可能导致抗癌治疗的效果不足最佳或偏离目标.
- 了解这些机制对于开发更有效的免疫治疗策略对抗癌症至关重要.
相关概念视频
Antigen Processing Pathways
925
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
925
Antigen Presenting Cells
1.7K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
1.7K
Antigens Involved in Adaptive Immunity
452
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
452
Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
T Cell Activation and Clonal Selection
655
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
655
Cell-mediated Immune Responses
66.9K
Overview
66.9K


